Description

Breo Ellipta is a prescription medication used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains a combination of fluticasone furoate and vilanterol, which work together to reduce inflammation and relax the airways.

Interpreter Notes

Interpreters should be aware that patients may refer to Breo Ellipta simply as 'Breo' or use the brand name without the full designation. It is important to maintain a formal register and avoid colloquial terms when discussing this medication in clinical settings.

Example Sentences

EN: The doctor prescribed Breo Ellipta to help manage the patient's asthma symptoms.

ES: El médico recetó Breo Ellipta para ayudar a controlar los síntomas del asma del paciente.

Common Interpreter Mistakes

Confusing Breo Ellipta with other inhalers; mispronouncing the medication name; using informal language when discussing the medication